Instituto Nacional de Ciencias Médicas y Nutrición Dr. Salvador Zubirán

Vasco de Quiroga 15, Belisario Domínguez Secc 16, 14080 Ciudad de México

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Carlos Alberto Aguilar Salinas

Valeria Rebollar Fernandez

Adriana Miguel Álvarez

Tatiana Sofía Rodríguez Reyna

Hilda Fragoso-Loyo

Cristina Paredes Salomon

Ricardo A Castillejos Molina

Norma A Bobadilla Sandoval

Miguel Ángel Gómez Sámano

Virginia Pascual

Irazu Contreras

Guillermo Guaracha

Silvia Méndez Flores

Monserrat Velasco

Erwin Chiquete Anaya

Open studies

Polyneuropathy

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP - emnergize - argenxSee more

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP - emvigorate - argenxSee more

Cardiovascular disease

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more

Obesity

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more

Sleep disorders

Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA) - MEBP-OSA - Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSee more

Colorectal cancer

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more

Prostate cancer

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) - IDeate-Prostate01 - Merck Sharp & Dohme LLCSee more

Diabetes

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications - AMBITION 7 - Novo Nordisk A/SSee more

Renal disease

Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study - DAKI-CKD - Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSee more

Solid tumors

Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity - DAPA-ARMOR - Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSee more